glutamic acid has been researched along with Psychoses, Drug in 23 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (8.70) | 18.2507 |
2000's | 8 (34.78) | 29.6817 |
2010's | 12 (52.17) | 24.3611 |
2020's | 1 (4.35) | 2.80 |
Authors | Studies |
---|---|
Li, W; Li, Y; Liu, D; Xiang, Q | 1 |
Brigo, F; Nardone, R; Tezzon, F | 1 |
Alameda, L; Baumann, PS; Cleusix, M; Conus, P; Do, KQ; Ferrari, C; Gruetter, R; Jenni, R; Klauser, P; Pompili, M; Rigucci, S; Xin, L | 1 |
Berquist, MD; Fantegrossi, WE; Wilson, CD | 1 |
Bertron, JL; Lindsley, CW; Seto, M | 1 |
Cuddy, T; de la Fuente Revenga, M; Dozmorov, MG; González-Maeso, J; Holloway, T; Ibi, D; Ijaz, MK; Kurita, M; Saunders, JM; Seto, J; Shen, L; Toneatti, R | 1 |
Mill, J; Rutten, BP | 1 |
Colaianna, M; Cuomo, V; Dubois-Dauphin, M; Jaquet, V; Krause, KH; Schiavone, S; Sorce, S; Trabace, L; Tucci, P | 1 |
Corlett, PR; Fletcher, PC; Honey, GD; Krystal, JH | 1 |
Gao, L; He, G; He, L; Huang, K; Ji, B; Li, Y; Sun, L; Wan, C; Wei, Z; Yang, J; Zhang, M; Zhang, Z; Zhou, K; Zhu, H | 1 |
Gururajan, A; Klug, M; Manning, EE; van den Buuse, M | 1 |
Krystal, JH; Moghaddam, B | 1 |
Javitt, DC | 2 |
Coyle, JT | 1 |
Heinz, A; Lieb, K; Pich, M; Schaefer, M; Schwaiger, M | 1 |
Honda, M | 1 |
Engberg, G; Erhardt, S; Schwieler, L | 1 |
Aalto, S; Gustafsson, LL; Hietala, J; Hirvonen, J; Ihalainen, J; Kajander, J; Någren, K; Scheinin, H; Syvälahti, E; Tanila, H; Vilkman, H | 1 |
Ballmaier, M; Bortolato, M; Gessa, G; Heinz, A; Rizzetti, C; Spano, P; Zoli, M | 1 |
Deakin, JF; Dursun, SM; Hallak, JE; Lees, J; McKie, S; Williams, SR | 1 |
Koffel, B; Lahti, AC; LaPorte, D; Tamminga, CA | 1 |
Abekawa, T | 1 |
8 review(s) available for glutamic acid and Psychoses, Drug
Article | Year |
---|---|
Pro-psychotic effects of synthetic cannabinoids: interactions with central dopamine, serotonin, and glutamate systems.
Topics: Animals; Cannabinoids; Dopamine; Glutamic Acid; Humans; Illicit Drugs; Marijuana Abuse; Psychoses, Substance-Induced; Schizophrenia; Serotonin | 2018 |
DARK Classics in Chemical Neuroscience: Phencyclidine (PCP).
Topics: Glutamic Acid; Hallucinogens; History, 20th Century; History, 21st Century; Humans; Phencyclidine; Psychoses, Substance-Induced; Receptors, N-Methyl-D-Aspartate; Schizophrenia | 2018 |
Epigenetic mediation of environmental influences in major psychotic disorders.
Topics: Alleles; Bipolar Disorder; Child; Child Abuse; Diseases in Twins; DNA Methylation; Epigenesis, Genetic; Female; gamma-Aminobutyric Acid; Gene Expression Regulation; Glutamic Acid; Humans; Illicit Drugs; Parenting; Phenotype; Polymorphism, Genetic; Pregnancy; Prenatal Exposure Delayed Effects; Psychoses, Substance-Induced; Risk Factors; Schizophrenia; Schizophrenic Psychology; Social Environment | 2009 |
Glutamatergic model psychoses: prediction error, learning, and inference.
Topics: Animals; Bayes Theorem; Cognition; Excitatory Amino Acid Antagonists; Glutamic Acid; Humans; Learning; Models, Neurological; Psychoses, Substance-Induced; Psychotic Disorders; Receptors, Glutamate | 2011 |
Drugs of abuse and increased risk of psychosis development.
Topics: Age of Onset; Animals; Behavioral Symptoms; Brain; Cannabis; Dopamine; Dopamine Uptake Inhibitors; Functional Neuroimaging; Genetic Predisposition to Disease; Glutamic Acid; Humans; Illicit Drugs; Methamphetamine; Models, Animal; Psychoses, Substance-Induced; Risk Factors; Schizophrenia; Substance-Related Disorders | 2012 |
Capturing the angel in "angel dust": twenty years of translational neuroscience studies of NMDA receptor antagonists in animals and humans.
Topics: Allosteric Regulation; Animals; Antipsychotic Agents; Brief Psychiatric Rating Scale; Cerebral Cortex; Disease Models, Animal; Dopamine; Emotions; Glutamic Acid; Humans; Ketamine; Neurosciences; Phencyclidine; Psychoses, Substance-Induced; Receptor, Metabotropic Glutamate 5; Receptors, Dopamine D2; Receptors, Metabotropic Glutamate; Receptors, N-Methyl-D-Aspartate; Schizophrenia; Synapses; Translational Research, Biomedical | 2012 |
Neurotransmitter changes by interferon-alpha and therapeutic implications.
Topics: Animals; Confusion; Depression; Dopamine; Glutamic Acid; Humans; Interferon-alpha; Narcotic Antagonists; Neurotransmitter Agents; Norepinephrine; Paranoid Disorders; Psychoses, Substance-Induced; Receptors, Opioid; Selective Serotonin Reuptake Inhibitors; Serotonin; Suicide | 2003 |
Glutamate and schizophrenia: phencyclidine, N-methyl-D-aspartate receptors, and dopamine-glutamate interactions.
Topics: Animals; Antipsychotic Agents; Brain; Dopamine; Excitatory Amino Acid Antagonists; Glutamic Acid; Humans; Phencyclidine; Psychoses, Substance-Induced; Receptors, N-Methyl-D-Aspartate; Schizophrenia | 2007 |
2 trial(s) available for glutamic acid and Psychoses, Drug
Article | Year |
---|---|
Glutamate and the neural basis of the subjective effects of ketamine: a pharmaco-magnetic resonance imaging study.
Topics: Adult; Anticonvulsants; Awareness; Brain; Brief Psychiatric Rating Scale; Cross-Over Studies; Dissociative Disorders; Double-Blind Method; Excitatory Amino Acid Antagonists; Frontal Lobe; Glutamic Acid; Gyrus Cinguli; Humans; Image Enhancement; Image Processing, Computer-Assisted; Infusions, Intravenous; Ketamine; Lamotrigine; Magnetic Resonance Imaging; Male; Oxygen; Premedication; Psychoses, Substance-Induced; Receptors, N-Methyl-D-Aspartate; Statistics as Topic; Triazines | 2008 |
Subanesthetic doses of ketamine stimulate psychosis in schizophrenia.
Topics: Adult; Dose-Response Relationship, Drug; Double-Blind Method; Female; Glutamic Acid; Haloperidol; Humans; Injections, Intravenous; Ketamine; Male; Middle Aged; Psychoses, Substance-Induced; Schizophrenia; Time Factors | 1995 |
13 other study(ies) available for glutamic acid and Psychoses, Drug
Article | Year |
---|---|
Disrupted Coupling Between NAA and Functional Connectivity in Ventromedial Prefrontal Cortex of Drug-Naïve First-Episode Psychosis.
Topics: Aspartic Acid; Glutamic Acid; Humans; Prefrontal Cortex; Psychoses, Substance-Induced | 2020 |
Forced normalization and antiepileptic drugs interacting with glutamatergic neurotransmission: Caution is needed.
Topics: Adult; Anticonvulsants; Drug Resistant Epilepsy; Electroencephalography; Female; Glutamic Acid; Humans; Levetiracetam; Nitriles; Psychoses, Substance-Induced; Pyridones; Synaptic Transmission; Topiramate; Zonisamide | 2017 |
Cannabis use in early psychosis is associated with reduced glutamate levels in the prefrontal cortex.
Topics: Adolescent; Adult; Diagnostic and Statistical Manual of Mental Disorders; Female; Glutamic Acid; Humans; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Male; Marijuana Abuse; Memory, Short-Term; Neuropsychological Tests; Prefrontal Cortex; Psychomotor Performance; Psychoses, Substance-Induced; Signal Transduction; Socioeconomic Factors; Young Adult | 2018 |
HDAC2-dependent Antipsychotic-like Effects of Chronic Treatment with the HDAC Inhibitor SAHA in Mice.
Topics: Animals; Antipsychotic Agents; Cerebral Cortex; Cognition; Gene Expression Regulation; Glutamic Acid; Histone Deacetylase 2; Histone Deacetylase Inhibitors; Male; Mice, Inbred C57BL; Mice, Knockout; Psychoses, Substance-Induced; Pyramidal Cells; Random Allocation; Synapses; Vorinostat | 2018 |
The NADPH oxidase NOX2 controls glutamate release: a novel mechanism involved in psychosis-like ketamine responses.
Topics: Animals; Disease Models, Animal; Glutamic Acid; Ketamine; Membrane Glycoproteins; Mice; Mice, Inbred C57BL; Mice, Knockout; Motor Activity; NADPH Oxidase 2; NADPH Oxidases; Prefrontal Cortex; Psychoses, Substance-Induced; Reactive Oxygen Species | 2010 |
Proteome alterations of cortex and hippocampus tissues in mice subjected to vitamin A depletion.
Topics: Actins; Animals; Cerebral Cortex; Dizocilpine Maleate; Electrophoresis, Gel, Two-Dimensional; Female; Glutamic Acid; Hippocampus; Intercellular Signaling Peptides and Proteins; Male; Mass Spectrometry; Mice; Mice, Inbred C57BL; Mitogen-Activated Protein Kinase 1; Nerve Tissue Proteins; Proteasome Endopeptidase Complex; Proteome; Psychoses, Substance-Induced; Psychotic Disorders; Receptors, Dopamine; Signal Transduction; Two-Dimensional Difference Gel Electrophoresis; Vitamin A Deficiency | 2011 |
Twenty-five years of glutamate in schizophrenia: are we there yet?
Topics: Antipsychotic Agents; Glutamic Acid; History, 20th Century; History, 21st Century; Humans; Phencyclidine; Psychoses, Substance-Induced; Receptors, N-Methyl-D-Aspartate; Schizophrenia | 2012 |
NMDA receptor and schizophrenia: a brief history.
Topics: Anesthetics, Dissociative; Animals; Antipsychotic Agents; Disease Models, Animal; Glutamic Acid; History, 20th Century; History, 21st Century; Humans; Neurosciences; Phencyclidine Abuse; Psychopharmacology; Psychoses, Substance-Induced; Rats; Receptors, N-Methyl-D-Aspartate; Schizophrenia; Translational Research, Biomedical | 2012 |
[The relation between behavioral sensitization and glutamate release on the animal model of methamphetamine-induced psychosis].
Topics: Animals; Behavior, Animal; Dopamine; Glutamic Acid; Male; Methamphetamine; Models, Animal; Nucleus Accumbens; Psychoses, Substance-Induced; Rats; Rats, Wistar | 2004 |
Kynurenic acid and schizophrenia.
Topics: Animals; Antipsychotic Agents; Dopamine; Glutamic Acid; Humans; Kynurenic Acid; Male; Models, Neurological; Phencyclidine; Psychoses, Substance-Induced; Rats; Rats, Sprague-Dawley; Schizophrenia; Ventral Tegmental Area | 2003 |
Cortical glutamate-dopamine interaction and ketamine-induced psychotic symptoms in man.
Topics: Adult; Animals; Carbon Radioisotopes; Cerebral Cortex; Dopamine; Excitatory Amino Acid Antagonists; Glutamic Acid; Humans; Ketamine; Male; Microdialysis; Positron-Emission Tomography; Psychoses, Substance-Induced; Pyrrolidines; Rats; Salicylamides | 2005 |
Cannabinoid receptor antagonists counteract sensorimotor gating deficits in the phencyclidine model of psychosis.
Topics: Animals; Brain; Cannabinoid Receptor Antagonists; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Interactions; Drug Synergism; Excitatory Amino Acid Antagonists; Glutamic Acid; Male; Phencyclidine; Piperidines; Psychoses, Substance-Induced; Pyrazoles; Rats; Receptors, Cannabinoid; Reflex, Startle; Rimonabant; Schizophrenia; Sensation Disorders; Synaptic Transmission | 2007 |
[Experimental study of methamphetamine psychosis--role of glutamate and nitric oxide in methamphetamine-induced dopaminergic and serotonergic neurotoxicity in the rat brain].
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Brain; Corpus Striatum; Dopamine; Glutamic Acid; Hydroxyindoleacetic Acid; Male; Methamphetamine; Microdialysis; Nitric Oxide; Nucleus Accumbens; Psychoses, Substance-Induced; Rats; Rats, Wistar; Receptors, N-Methyl-D-Aspartate; Serotonin | 1997 |